EP1360293 - SEQUENCES INVOLVED IN PHENOMENA OF TUMOUR SUPPRESSION, TUMOUR REVERSION, APOPTOSIS AND/OR VIRUS RESISTANCE AND THEIR USE AS MEDICINES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.06.2008 Database last updated on 13.11.2024 | Most recent event Tooltip | 13.06.2008 | Application deemed to be withdrawn | published on 16.07.2008 [2008/29] | Applicant(s) | For all designated states Molecular Engines Laboratories 20, rue Bouvier 75011 Paris / FR | [2003/46] | Inventor(s) | 01 /
TELERMAN, Adam 6, rue du Pré-aux-Clercs F-75007 Paris / FR | 02 /
AMSON, Robert 10, rue Gay-Lussac F-75005 Paris / FR | 03 /
TUIJNDER, Marcel Moestuinstraat 2 B-2800 Mechelen / BE | 04 /
SUSINI, Laurent 5 rue du Trèfle F-95160 Montmorency / FR | [2004/04] |
Former [2003/46] | 01 /
TELERMAN, Adam 6, rue du Pré-aux-Clercs F-75007 Paris / FR | ||
02 /
AMSON, Robert 10, rue Gay-Lussac F-75005 Paris / FR | |||
03 /
TUIJNDER, Marcel Moestuinstraat 2 B-2800 Mechelen / BE | |||
04 /
SUSINI, Laurent 3, allée Maurice Ravel F-93160 Noisy-le-Grand / FR | Representative(s) | Texier, Christian, et al Cabinet Regimbeau 20, rue de Chazelles 75847 Paris Cedex 17 / FR | [N/P] |
Former [2003/46] | Texier, Christian, et al Cabinet Régimbeau 20, rue de Chazelles 75847 Paris cedex 17 / FR | Application number, filing date | 02708409.4 | 13.02.2002 | [2003/46] | WO2002FR00543 | Priority number, date | FR20010001925 | 13.02.2001 Original published format: FR 0101925 | [2003/46] | Filing language | FR | Procedural language | FR | Publication | Type: | A2 Application without search report | No.: | WO02064731 | Date: | 22.08.2002 | Language: | FR | [2002/34] | Type: | A2 Application without search report | No.: | EP1360293 | Date: | 12.11.2003 | Language: | FR | The application published by WIPO in one of the EPO official languages on 22.08.2002 takes the place of the publication of the European patent application. | [2003/46] | Search report(s) | International search report - published on: | EP | 06.03.2003 | Classification | IPC: | C07K14/47, C07K16/18, C12N15/63, C12N15/10, C12Q1/68, G01N33/53, A61K48/00, A61K39/395, A61K38/17, A01K67/027 | [2007/35] | CPC: |
C07K14/47 (EP,US);
A61P25/00 (EP);
A61P31/12 (EP);
A61P35/00 (EP);
A01K2217/05 (EP,US);
C12N2799/021 (EP,US)
|
Former IPC [2003/46] | C12N15/12, C07K14/47, C07K16/18, C12N15/63, C12N15/10, C12Q1/68, G01N33/53, A61K48/00, A61K39/395, A61K38/17, A61P35/00, A61P31/12, A61P25/00, A01K67/027 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/46] | Title | German: | SEQUENZEN DIE AN DER TUMORUNTERDRÜCKUNG, TUMORUMKEHRUNG, APOPTOSIS, UND/ODER VIRUSRESISTENZ BETEILIGT SIND, UND IHRE VERWENDUNG ALS ARZNEIMITTEL | [2007/37] | English: | SEQUENCES INVOLVED IN PHENOMENA OF TUMOUR SUPPRESSION, TUMOUR REVERSION, APOPTOSIS AND/OR VIRUS RESISTANCE AND THEIR USE AS MEDICINES | [2003/46] | French: | SEQUENCES IMPLIQUEES DANS LES PHENOMENES DE SUPPRESSION TUMORALE, REVERSION TUMORALE, APOPTOSE ET/OU RESISTANCE AUX VIRUS ET LEUR UTILISATION COMME MEDICAMENTS | [2003/46] |
Former [2003/46] | SEQUENZE DIE IN DER TUMORUNTERDRÜCKUNG, TUMORUMKEHRUNG, APOPTOSIS, UND/ODER VIRUSRESISTENZ BETEILIGT SIND, UND IHRE VERWENDUNG ALS ARZNEIMITTEL | Entry into regional phase | 01.09.2003 | National basic fee paid | 01.09.2003 | Designation fee(s) paid | 01.09.2003 | Examination fee paid | Examination procedure | 10.09.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 01.09.2003 | Examination requested [2003/46] | 09.12.2004 | Despatch of a communication from the examining division (Time limit: M04) | 06.04.2005 | Reply to a communication from the examining division | 21.07.2005 | Despatch of a communication from the examining division (Time limit: M04) | 30.11.2005 | Reply to a communication from the examining division | 28.04.2006 | Despatch of a communication from the examining division (Time limit: M04) | 01.08.2006 | Reply to a communication from the examining division | 21.08.2006 | Despatch of a communication from the examining division (Time limit: M04) | 12.12.2006 | Reply to a communication from the examining division | 10.09.2007 | Communication of intention to grant the patent | 22.01.2008 | Application deemed to be withdrawn, date of legal effect [2008/29] | 26.02.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2008/29] | Fees paid | Renewal fee | 01.09.2003 | Renewal fee patent year 03 | 21.02.2005 | Renewal fee patent year 04 | 20.02.2006 | Renewal fee patent year 05 | 26.02.2007 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 29.02.2008 | 07   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]WO9412881 (HOCHSTRASSER DENIS F [CH], et al) [X] 1-4 * abstract * [Y] 1-30; | [Y]FR2782085 (FONDATION JEAN DAUSSET CEPH [FR]) [Y] 1-30 * abstract * * page 1, line 5 - line 10 * * page 2, line 16 - line 25 * * page 3, line 22 - line 26 * * page 5, line 4 - page 6, line 21 * * page 7, line 19 - line 22 *; | [A]US5952179 (CHINNADURAI GOVINDASWAMY [US]) [A] 2 * column A *; | [X] - NCI-CGAP, "tz08a06.x1 NCI_CGAP_Ut1 Homo sapiens cDNA clone IMAGE:2287954 3' similar to gb:X16064 TRANSLATIONALLY CONTROLLED TUMOR PROTEIN (HUMAN);, mRNA sequence", EM_EST, EMBL, (19990427), Database accession no. AI635631, URL: EBI, XP002209854 [X] 1,2 * the whole document * | [X] - NCI-CGAP, "tr64c07.x1 NCI_CGAP_Pan1 Homo sapiens cDNA clone IMAGE:2223084 3' similar to gb:X16064 TRANSLATIONALLY CONTROLLED TUMOR PROTEIN (HUMAN);, mRNA sequence", EM_EST, EMBL, (19990329), Database accession no. AI567685, URL: EBI, XP002209855 [X] 1,2 * the whole document * | [A] - LI ET AL, "A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, (19971121), vol. 272, no. 47, ISSN 0021-9258, pages 29403 - 29406, XP002159206 [A] 2 * abstract * DOI: http://dx.doi.org/10.1074/jbc.272.47.29403 | [DA] - BRENNER ET AL., "In vitro cloning of complex mixtures of DNA on microbeads: Physical separation of differentially expressed cDNAs", PROCEEDINGS OF THE NATINAL ACADEMY OF SCIENCES USA, (20000215), vol. 97, no. 4, pages 1665 - 1670, XP002183229 DOI: http://dx.doi.org/10.1073/pnas.97.4.1665 | [A] - SALESIOTIS A N ET AL, "IDENTIFICATION OF NOVEL GENES FROM STOMACH CANCER CELL LINES BY DIFFERENTIAL DISPLAY", CANCER LETTERS, NEW YORK, NY, US, (1995), vol. 91, ISSN 0304-3835, pages 47 - 54, XP002917863 [A] * abstract * * page 51, column R * DOI: http://dx.doi.org/10.1016/0304-3835(95)03717-B |